On May 13, Research!America will join with organizations AcademyHealth, Allergy and Asthma Network, Asthma and Allergy Foundation of America, and GlaxoSmithKline to host the third in a series of congressional briefings featuring basic, clinical, population and health services researchers, as well as the patient perspective. This briefing will illustrate the value of federally-funded research across the continuum in the fight against asthma and allergies.
Lisa Simpson, M.B., B.Ch., MPH, the president and CEO of AcademyHealth, will serve as the moderator and guide the audience through each part of the research continuum. Speakers include patient advocates Vernetta Santos and family; Kirk Druey, M.D., National Institute of Allergy and Infectious Diseases (NIAID) representing the basic research perspective; Catherine Bonuccelli, M.D., GlaxoSmithKline, representing clinical research; Tyra Bryant-Stephens, M.D., The Children’s Hospital of Philadelphia representing population research; and Michael Cabana, M.D., MPH., University of California, San Francisco (UCSF) representing health services research.
May marks National Asthma and Allergy Awareness Month. This is an opportune time to discuss the research continuum while using asthma and allergies as a case study. Asthma results in 1.8 million ER visits per year and 1 in 10 children suffer from respiratory allergies.
The research continuum briefing series provides an educational opportunity for policymakers and their staff to learn about the distinct, yet equally important, types of research across the discovery, development, delivery spectrum that are working together to address disease. For more information, click here.